- Home
- VANI vs MNOV Comparison
VANI vs MNOV Comparison
Compare VANI & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- MNOV
- Stock Information
- Founded
- VANI 1998
- MNOV 2000
- Country
- VANI United States
- MNOV United States
- Employees
- VANI 36
- MNOV N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- VANI Health Care
- MNOV Health Care
- Exchange
- VANI Nasdaq
- MNOV Nasdaq
- Market Cap
- VANI 75.2M
- MNOV 68.2M
- IPO Year
- VANI 2014
- MNOV 2005
- Fundamental
- Price
- VANI $1.40
- MNOV $1.27
- Analyst Decision
- VANI Strong Buy
- MNOV Strong Buy
- Analyst Count
- VANI 1
- MNOV 2
- Target Price
- VANI $4.00
- MNOV $7.00
- AVG Volume (30 Days)
- VANI 134.3K
- MNOV 17.6K
- Earning Date
- VANI 08-12-2025
- MNOV 08-07-2025
- Dividend Yield
- VANI N/A
- MNOV N/A
- EPS Growth
- VANI N/A
- MNOV N/A
- EPS
- VANI N/A
- MNOV N/A
- Revenue
- VANI N/A
- MNOV N/A
- Revenue This Year
- VANI N/A
- MNOV N/A
- Revenue Next Year
- VANI N/A
- MNOV N/A
- P/E Ratio
- VANI N/A
- MNOV N/A
- Revenue Growth
- VANI N/A
- MNOV N/A
- 52 Week Low
- VANI $0.91
- MNOV $1.12
- 52 Week High
- VANI $1.50
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- VANI 74.26
- MNOV 40.89
- Support Level
- VANI $1.26
- MNOV $1.32
- Resistance Level
- VANI $1.30
- MNOV $1.38
- Average True Range (ATR)
- VANI 0.06
- MNOV 0.05
- MACD
- VANI 0.00
- MNOV -0.00
- Stochastic Oscillator
- VANI 69.70
- MNOV 15.38
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.